Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing.

International journal of molecular sciences - 29 Jan 2022

Huang Chi-Cheng, Liu Chih-Yi, Huang Chi-Jung, Hsu Yao-Chun, Lien Heng-Hui, Wong Jia-Uei, Tai Feng-Chuan, Ku Wen-Hui, Hung Chi-Feng, Lin Jaw-Town, Huang Ching-Shui, Chiang Han-Sun

Abstract excerpt

Pancreatic adenocarcinoma (PAC) is the 8th leading cause of cancer-related deaths in Taiwan, and its incidence is increasing. The development of PAC involves successive accumulation of multiple genetic alterations. Understanding the molecular pathogenesis and heterogeneity of PAC may facilitate personalized treatment for PAC and identify therapeutic agents. We performed tumor-only next-generation sequencing (NGS)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasm Metastasis
Share to Adenocarcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pancreatic Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Share to Receptor, Fibroblast Growth Factor, Type 2

Share to Receptor, Platelet-Derived Growth Factor alpha

Share to Taiwan

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 35163506
DOI: 10.3390/ijms23031579
PMCID: PMC8835797

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing.PMID 35163506Read ↗

Deciphering Genetic Alterations of Taiwanese Pancreatic Adenocarcinoma With Targeted SequencingSemantic proximity Read ↗

Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation SequencingSemantic proximity Read ↗

Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.Semantic proximity Read ↗

Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implicationsSemantic proximity Read ↗

TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing.Semantic proximity Read ↗

NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancerSemantic proximity Read ↗

Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.Semantic proximity Read ↗

Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort.Semantic proximity Read ↗

Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer.Semantic proximity Read ↗

Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencingSemantic proximity Read ↗

Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel OpportunitiesSemantic proximity Read ↗

Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.